LPL Financial
MDGL icon

LPL Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

LPL Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.73M Sell
7,409
-1,018
-12% -$538K ﹤0.01% 3136
2026
Q2 		$4.52M Sell
8,427
-979
-10% -$501K ﹤0.01% 2899
2026
Q1 		$4.92M Sell
9,406
-7,136
-43% -$3.41M ﹤0.01% 2636
2025
Q4 		$9.6M Sell
16,542
-5,996
-27% -$3.06M ﹤0.01% 1962
2025
Q3 		$10.3M Buy
22,538
+8,417
+60% +$3.14M ﹤0.01% 1834
2025
Q2 		$4.27M Sell
14,121
-16,701
-54% -$4.98M ﹤0.01% 2446
2025
Q1 		$10.2M Buy
30,822
+25,602
+490% +$8.41M ﹤0.01% 1588
2024
Q4 		$1.61M Buy
5,220
+480
+10% +$135K ﹤0.01% 3064
2024
Q3 		$1.01M Sell
4,740
-438
-8% -$112K ﹤0.01% 3397
2024
Q2 		$1.45M Buy
5,178
+1,749
+51% +$416K ﹤0.01% 2905
2024
Q1 		$916K Sell
3,429
-143
-4% -$33.7K ﹤0.01% 3265
2023
Q4 		$826K Buy
+3,572
New +$625K ﹤0.01% 3216
2023
Q3 		– Sell
-1,010
Closed -$233K – 4753
2023
Q2 		$233K Buy
1,010
+184
+22% +$49.8K ﹤0.01% 4042
2023
Q1 		$200K Sell
826
-57
-6% -$15.5K ﹤0.01% 4048
2022
Q4 		$256K Buy
+883
New +$86.4K ﹤0.01% 3791
2022
Q2 		– Sell
-3,768
Closed -$370K – 4499
2022
Q1 		$370K Buy
+3,768
New +$318K ﹤0.01% 3412
2021
Q4 		– Sell
-2,813
Closed -$224K – 4411
2021
Q3 		$224K Sell
2,813
-205
-7% -$17.7K ﹤0.01% 3881
2021
Q2 		$294K Buy
3,018
+675
+29% +$79.9K ﹤0.01% 3603
2021
Q1 		$274K Buy
+2,343
New +$273K ﹤0.01% 3543
2019
Q1 		– Sell
-2,260
Closed -$255K – 3225
2018
Q4 		$255K Buy
2,260
+947
+72% +$147K ﹤0.01% 2593
2018
Q3 		$281K Sell
1,313
-10
-0.8% -$2.51K ﹤0.01% 2755
2018
Q2 		$370K Buy
+1,323
New +$232K ﹤0.01% 2459

Other funds holding MDGL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

LPL Financial's MDGL Position: Q3 2026 in Review

LPL Financial reduced its Madrigal Pharmaceuticals (MDGL) stake by 12% in Q3 2026, selling an estimated $538K and leaving 7,409 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3136.

LPL Financial first reported a position in MDGL in Q2 2018 and has held it in 22 quarters since. The position peaked at $10.3M in Q3 2025. 184 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • LPL Financial held 7,409 shares of Madrigal Pharmaceuticals worth $3.73M as of Q3 2026.
  • LPL Financial sold 1,018 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $538K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #3136 holding.
  • LPL Financial first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 22 quarters since.
  • LPL Financial's Madrigal Pharmaceuticals position peaked at $10.3M in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.